Cargando…

Aptamer BC 007’s Affinity to Specific and Less-Specific Anti-SARS-CoV-2 Neutralizing Antibodies

COVID-19 is a pandemic respiratory disease that is caused by the highly infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Anti-SARS-CoV-2 antibodies are essential weapons that a patient with COVID-19 has to combat the disease. When now repurposing a drug, namely an aptamer tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haberland, Annekathrin, Krylova, Oxana, Nikolenko, Heike, Göttel, Peter, Dallmann, Andre, Müller, Johannes, Weisshoff, Hardy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157297/ https://www.ncbi.nlm.nih.gov/pubmed/34069827 http://dx.doi.org/10.3390/v13050932

Ejemplares similares

Aptamer BC 007 - Efficient binder of spreading-crucial SARS-CoV-2 proteins
por: Weisshoff, Hardy, et al.
Publicado: (2020)

In-Vivo Degradation of DNA-Based Therapeutic BC 007 in Humans
por: Davideit, Hanna, et al.
Publicado: (2019)

The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman Pinschers of efficacy and outcomes
por: Werner, Sabine, et al.
Publicado: (2020)

Aptamers Against COVID-19: An Untested Opportunity
por: Haberland, Annekathrin, et al.
Publicado: (2022)

A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects
por: Becker, Niels-Peter, et al.
Publicado: (2020)

Multiple Therapeutic Applications of RBM-007, an Anti-FGF2 Aptamer
por: Nakamura, Yoshikazu
Publicado: (2021)

Selection of DNA Aptamers against Glioblastoma Cells with High Affinity and Specificity
por: Kang, Dezhi, et al.
Publicado: (2012)

Identification of two aptamers binding to Legionella pneumophila with high affinity and specificity
por: Saad, Mariam, et al.
Publicado: (2020)

Evidence for a Novel Mechanism of Antimicrobial Action of a Cyclic R-,W-Rich Hexapeptide
por: Scheinpflug, Kathi, et al.
Publicado: (2015)

Selection and application of aptamers with high-affinity and high-specificity against dinophysistoxin-1
por: Li, Zhen, et al.
Publicado: (2020)

Lack of efficacy of mono‐mode of action therapeutics in COVID‐19 therapy ‐ How the lack of predictive power of preclinical cell and animal studies leads developments astray
por: Haberland, Annekathrin, et al.
Publicado: (2021)

Investigating the Role of Sulfate Groups for the Binding of Gd(3+) Ions to Glycosaminoglycans with NMR Relaxometry
por: Werner, Patrick, et al.
Publicado: (2022)

Specific capture and detection of Staphylococcus aureus with high-affinity modified aptamers to cell surface components
por: Baumstummler, A, et al.
Publicado: (2014)

A DNA aptamer with high affinity and specificity for molecular recognition and targeting therapy of gastric cancer
por: Cao, Hong-Yong, et al.
Publicado: (2014)

Selection and identification of high‐affinity aptamer of Kunitz trypsin inhibitor and their application in rapid and specific detection
por: Bao, Yunxiang, et al.
Publicado: (2022)

The use of high-affinity polyhistidine binders as masking probes for the selection of an NDM-1 specific aptamer
por: Sabrowski, Wiebke, et al.
Publicado: (2022)

Improvement of Aptamer Affinity by Dimerization
por: Hasegawa, Hijiri, et al.
Publicado: (2008)

Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling—Additional Information About TLR9 Involvement
por: Haberland, Annekathrin, et al.
Publicado: (2019)

Methods for Improving Aptamer Binding Affinity
por: Hasegawa, Hijiri, et al.
Publicado: (2016)

Specificity And Affinity
Publicado: (2007)

Antigen-free control wells in an ELISA set-up for the determination of autoantibodies against G protein-coupled receptors—a requisite for correct data evaluation
por: Haberland, Annekathrin, et al.
Publicado: (2018)

Using modified aptamers for site specific protein–aptamer conjugations
por: Wang, Ruowen, et al.
Publicado: (2016)

Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
por: Hohberger, Bettina, et al.
Publicado: (2021)

Characterization of the high-affinity anti-CTLA-4 monoclonal antibody JS007 for immune checkpoint therapy of cancer
por: Guan, Jiawei, et al.
Publicado: (2022)

A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry
por: Valero, Julián, et al.
Publicado: (2021)

Induction of neutralizing antibodies specific for the envelope proteins of the koala retrovirus by immunization with recombinant proteins or with DNA
por: Fiebig, Uwe, et al.
Publicado: (2015)

Cell-Specific Aptamers as Emerging Therapeutics
por: Meyer, Cindy, et al.
Publicado: (2011)

Selection of Aptamers Specific for Adipose Tissue
por: Liu, Jun, et al.
Publicado: (2012)

Rapid Complexation of Aptamers by Their Specific Antidotes
por: Stoll, Heidi, et al.
Publicado: (2017)

Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity
por: Pan, Qing, et al.
Publicado: (2018)

The Influence of Protein Charge and Molecular Weight on the Affinity of Aptamers
por: Drees, Alissa, et al.
Publicado: (2023)

Difference between beta1-adrenoceptor autoantibodies of human and animal origin—Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology
por: Wenzel, Katrin, et al.
Publicado: (2018)

Aptamer-targeted cell-specific RNA interference
por: Zhou, Jiehua, et al.
Publicado: (2010)

Isolation of an Aptamer that Binds Specifically to E. coli
por: Marton, Soledad, et al.
Publicado: (2016)

RNA Aptamers with Specificity for Heparosan and Chondroitin Glycosaminoglycans
por: Kizer, Megan, et al.
Publicado: (2018)

The selection of aptamers specific for membrane molecular targets
por: Janas, Teresa, et al.
Publicado: (2010)

Lipid Specific Membrane Interaction of Aptamers and Cytotoxicity
por: Ashrafuzzaman, Md., et al.
Publicado: (2021)

Probing the Limits of Aptamer Affinity with a Microfluidic SELEX Platform
por: Ahmad, Kareem M., et al.
Publicado: (2011)

Microarrays as Model Biosensor Platforms to Investigate the Structure and Affinity of Aptamers
por: Martin, Jennifer A., et al.
Publicado: (2016)

Target Affinity and Structural Analysis for a Selection of Norovirus Aptamers
por: Schilling-Loeffler, Katja, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m9nl5pcsohl6570npujhn3cadv